Disability Inclusion & Accessibility Federal Autism Panel’s Push for "Profound Autism" Label Sparks Controversy Amidst Procedural Concerns Lina IrawanMay 11, 2026016 mins A significant shift within a key federal autism advisory panel, orchestrated by U.S. Secretary of Health and Human Services Robert…
Disability Inclusion & Accessibility FDA Withdraws Approval of Wellcovorin, a Branded Version of Leucovorin, Ending Controversial Autism Treatment Push Lina IrawanApril 17, 2026012 mins The U.S. Food and Drug Administration (FDA) has officially withdrawn its approval for Wellcovorin, the branded formulation of leucovorin, marking…